Supernus Pharmaceuticals (SUPN) Tax Rate (2011 - 2025)
Supernus Pharmaceuticals' (SUPN) quarterly Tax Rate came in at 114.47% in Q4 2025, down 15637.0% year-on-year from N/an in Q4 2024, and down 616.8% on a QoQ basis from 22.15% in Q3 2025.
Supernus Pharmaceuticals (SUPN) Tax Rate (2011 - 2025) Analysis & Trends
Supernus Pharmaceuticals (SUPN) has 12 years of Tax Rate data on file, last reported at 114.47% in Q4 2025.
- On a quarterly basis, Tax Rate fell 15637.0% year-over-year to 114.47% in Q4 2025; TTM through Dec 2025 was 21.37%, a 310.0% decrease from a year earlier, with the FY2025 full-year figure at 21.37%, down 315.0% from the prior year.
- Tax Rate for Q4 2025 stood at 114.47%, down from 22.15% in the prior quarter.
- Over the last five years, Tax Rate for SUPN reached as high as 493.92% in Q3 2022 and fell as low as 114.47% in Q4 2025.
- Historically, Tax Rate has averaged 34.89% across 5 years, with a median of 24.19% in 2024.
- Across the five-year window, Tax Rate jumped 46837 bps in 2022 and plunged 24731 bps in 2024, its largest moves.
- Year by year, Tax Rate stood at 19.06% in 2021, then jumped by 244 bps to 27.41% in 2022, then sank by 168 bps to 18.69% in 2023, then jumped by 324 bps to 41.9% in 2024, then sank by 373 bps to 114.47% in 2025.
- Per Business Quant data, the three most recent Tax Rate figures were 114.47% in Q4 2025, 22.15% in Q3 2025, and 34.98% in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Tax Rate (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 15.33% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 20.71% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -23.33% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 13.63% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 171.33% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 19.81% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 34.48% |
| 10 | Supernus Pharmaceuticals | 2.72 Bn | 2.34 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -114.47% |
| Dec 31, 2025 | -114.47% |
| Dec 31, 2025 | -114.47% |
| Sep 30, 2025 | 22.15% |
| Sep 30, 2025 | 22.15% |
| Sep 30, 2025 | 22.15% |
| Jun 30, 2025 | -34.98% |
| Jun 30, 2025 | -34.98% |
| Jun 30, 2025 | -34.98% |
| Mar 31, 2025 | -102.83% |
| Mar 31, 2025 | -102.83% |
| Mar 31, 2025 | -102.83% |
| Dec 31, 2024 | 41.90% |
| Dec 31, 2024 | 41.90% |
| Dec 31, 2024 | 41.90% |
| Sep 30, 2024 | 14.24% |
| Sep 30, 2024 | 14.24% |
| Sep 30, 2024 | 14.24% |
| Jun 30, 2024 | 24.33% |
| Jun 30, 2024 | 24.33% |